Abstract
Many carcinogens and mutagens are electrophilic in nature and will react with nucleophilic sites in protein and nucleic acid. Determination of the extent of formation of these adducts of genotoxic agents with protein provides a practical method of monitoring human exposure and of determining the possible risk associated with the exposure. Proteins are predominately attacked on the cysteine, histidine and N-terminal amino acids. Hemoglobin is the most suitable protein for dose monitoring due to its ready availability and its long lifetime. Methods have been developed using capillary gas chromatography with mass spectrometry for determining S-methylcysteine, Nr-[2-hydroxyethyl]histidine and Nr-[2-hydroxypropyl]histidine in hemoglobin, allowing the monitoring of in vivo exposure of laboratory animals and humans to methylating agents, ethylene oxide and propylene oxide, respectively. A method for monitoring exposure to acrylamide has also been devised based on the determination by gas chromatography-mass spectrometry of the adduct formed with cysteine residues in hemoglobin.
An alternative method of dose monitoring of some methylating agents by the measurement of the urinary N-7-methylated guanine derived from alkylated DNA breakdown products has also been investigated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bailey E, Farmer PB, Lamb JH (1980) The enantiomer as internal standard for the quantitation of the alkylated amino acid S-methyl-L-cysteine in hemoglobin by gas chromatography-chemical ionisation mass spectrometry with single ion detection. J Chromatogr 200: 145–152
Bailey E, Connors TA, Farmer PB, Gorf SM, Rickard J (1981) Methylation of cysteine in hemaglobin following exposure to methylating agents. Cancer Res 41: 2514–2517
Campbell JB (1983) The synthesis of Nr-(2-hydroxypropyl) histidine, Nr-(2-hydroxyethyl)histidine, and their deuterated analogues. J Chem Soc Perkin Trans 1: 1213–1217
Ehrenberg L, Hiesche KD, Osterman-Golkar S, Wennberg I (1974) Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutat Res 24: 83–103
Farmer PB, Bailey E, Lamb JH, Connors TA (1980) Approach to the quantitation of alkylated amino acids in hemoglobin by gas chromatography-mass spectrometry. Biomed Mass Spec 7: 41–46
Farmer PB, Gorf SM, Bailey E (1982) Determination of hydroxypropylhistidine in hemoglobin as a measure of exposure to propylene oxide using high resolution gas chromatographymass spectrometry. Biomed Mass Spec 9: 69–71
Farmer PB, Shuker DEG, Bird I (1986) DNA and protein adducts as indicators of in vivo methylation by nitrosatable drugs. Carcinogenesis 7: 49–52
Hashimoto K, Aldridge WN (1970) Biochemical studies on acrylamide, a neurotoxic agent. Biochem Pharmacol 19: 2591–2604
Lijinsky W, Greenblatt M (1972) Carcinogen dimethylnitrosamine produced in vivo from nitrite and aminopyrine. Nature (New Biol) 218: 1174–1175
Osterman-Golkar S, Ehrenberg L, Segerbäck D, Hällström I (1976) Evaluation of genetic risk of alkylating agents II. Hemoglobin as a dose monitor. Mutat Res 34: 1–10
Osterman-Golkar S, Hultmark D, Segerbäck D, Calleman CJ, Göethe R, Ehrenberg L, Wachmeister CA (1977) Alkylation of DNA and proteins in mice exposed to vinyl chloride. Biochem Biophys Res Commun 76: 259–266
Osterman-Golkar S, Farmer PB, Segerbäck D, Bailey E, Calleman CJ, Svensson K, Ehrenberg L (1983) Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in hemoglobin. Teratogenesis Carcinogenesis and Mutagenesis 3: 395–405
Osterman-Golkar S, Bailey E, Farmer PB, Gorf SM, Lamb JH (1984) Monitoring exposure to propylene oxide through the determination of haemoglobin alkylation. Scand J Work Environ Health 10: 99–102
Segerbäck D, Calleman CJ, Ehrenberg L, Löfroth G, Osterman-Golkar S (1978) Evaluation of genetic risks of alkylating agents IV. Quantitative determination of alkylated amino acids in haemoglobin as a measure of the dose after treatment of mice with methyl methanesulphonate. Mutat Res 49: 71–82
Shaikh B, Huang SKS, Pontzer NJ (1980) Urinary excretion of methylated purines and 1-methylnicotinamide following administration of methylating carcinogens. Chem Biol Interact 30: 253–256
Shuker DEG, Bailey E, Gorf SM, Lamb JH, Farmer PB (1984a) Determination of N-7-[2H3]methyl guanine in rat urine by gas chromatography-mass spectrometry following administration of trideuteromethylating agents or precursors. Anal Biochem 140: 270–275
Shuker DEG, Bailey E, Farmer PB (1984b) Methylation of protein and nucleic acids in vivo: use of trideuteromethylating agents or precursors. In: Proceedings of the Eighth International Meeting on N-nitroso compounds, Banff, Alberta September 4–9, 1983. IARC Scientific Publications No 57, pp 589–594
Törnqvist M, Mowrer J, Jensen S, Ehrenberg L (1986) Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal Biochem 154: 255–266
Van Sittert NJ, De Jong G, Clare MG, Davies R, Dean BJ, Wren LJ, Wright AS (1985) Cytogenetic, immunological, and haematological effects in workers in an ethylene oxide manufacturing plant. Br J Indust Med 42: 19–26
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. med. Herbert Remmer on the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Bailey, E., Farmer, P.B. & Shuker, D.E.G. Estimation of exposure to alkylating carcinogens by the GC-MS determination of adducts to hemoglobin and nucleic acid bases in urine. Arch Toxicol 60, 187–191 (1987). https://doi.org/10.1007/BF00296978
Issue Date:
DOI: https://doi.org/10.1007/BF00296978